Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cesar Adrián Blanco-Gómez"'
Autor:
Leodan Jesús Pérez-Martín, Jersy Díaz-Roja, Miguel Varela-González, Cesar Adrián Blanco-Gómez, Kenia Montoto-Cáceres
Publikováno v:
Universidad Médica Pinareña, Vol 16, Iss 2, Pp e439-e439 (2020)
Introduction: chronic kidney disease is considered a growing socio-economic and public health problem for all systems worldwide. Objective: characterize hemodialysis older adults at “Abel Santamaria Cuadrado” General Teaching Hospital during 201
Externí odkaz:
https://doaj.org/article/54650b107acd420c86cb87ba9c38eaa7
Publikováno v:
Universidad Médica Pinareña, Vol 18, Iss 2, Pp e661-e661 (2022)
Introduction: pemphigoid vulgaris is a rare, severe, autoimmune disease with mucocutaneous involvement that has an aggressive course and chronic evolution. The origin depends on the interaction between predisposing genetic and environmental factors,
Externí odkaz:
https://doaj.org/article/9f9c8a204f2b4bdcb87dd290399f97d6
Publikováno v:
Universidad Médica Pinareña, Vol 18, Iss 2, Pp e645-e645 (2021)
Introduction: Langerhans cell histiocytosis (LCH) or Histiocytosis X is a benign proliferative disease affecting dendritic cells. It presents a wide clinical spectrum, from isolated eosinophilic bone granuloma to multisystem involvement with multiple
Externí odkaz:
https://doaj.org/article/bcb29914bda44b16866469b627b3f919
Publikováno v:
Universidad Médica Pinareña, Vol 0, Iss 0, Pp e645-e645 (2021)
Introduccion La histiocitosis de Células de Langerhans es una enfermedad proliferativa benigna que afecta a las células dendríticas. La etiología de la enfermedad continúa siendo controversial. Presenta un amplio espectro clínico, desde el gran
Externí odkaz:
https://doaj.org/article/378aea887fd848d69d4166ab30c42c62
Autor:
César Adrián Blanco-Gómez, Ana Lázara Delgado-Reyes, Laura Elena Valdés-Rocubert, Rolando David Hernández-Godínez, Martha Elena Gómez-Vázuez
Publikováno v:
Universidad Médica Pinareña, Vol 16, Iss 3, Pp e503-e503 (2020)
Introduction: RANIDO is a clinical trial extended to primary health care with the objective of assessing the efficiency of Cuban biotechnology products Racotumomab and Nimotuzumab for the treatment of non-small cell lung cancer. Objective: to charac
Externí odkaz:
https://doaj.org/article/a5dbe18652e6421eb6a7e3af857f8c2f